Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 26, 2019

SELL
$219.29 - $241.72 $5,043 - $5,559
-23 Closed
0 $0
Q4 2018

Jan 28, 2019

BUY
$278.5 - $352.75 $835 - $1,058
3 Added 15.0%
23 $7,000
Q4 2017

Jan 29, 2018

BUY
$307.64 - $344.58 $6,152 - $6,891
20
20 $6,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $20.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Guinness Asset Management LTD Portfolio

Follow Guinness Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guinness Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Guinness Asset Management LTD with notifications on news.